Skip to main content
NRIX logo
NRIX
(NASDAQ)
Nurix Therapeutics, Inc.
$23.74-- (--)
Loading... - Market loading

Nurix Therapeutics (NRIX) Stock Price & Financial Analysis

Nurix Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$22.87 - $24.17
52-Week High$25.09
52-Week Low$8.20
Open$23.42
Volume965.87K
Average Volume (3M)2.13M
Market Cap2.61B
Shares Outstanding110.07M
Price to Sales (P/S)36.40
Price to Book (P/B)5.43
EV/EBITDA-8.76
Revenue (TTM)71.78M
Net Income (TTM)-295.28M
Free Cash Flow (TTM)-271.85M
EPS (TTM)$-3.16
Profit Margin-411.37%
Operating Margin-439.26%
Return on Equity (ROE)-61.40%
Debt to Equity0.12
50-Day MA$19.46
200-Day MA$16.68
52-Week Change104.13%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Nurix Therapeutics

What is the current stock price for NRIX?

As of the latest trading session, NRIX stock trades at $23.74. The 52-week range is $8.20–$25.09, with a day range of $22.87–$24.17.

What is the P/E ratio for NRIX?

The P/E ratio (Price-to-Earnings) for NRIX is shown in the Key Statistics section. This valuation metric helps compare Nurix Therapeutics, Inc. to industry peers.

Does NRIX pay dividends?

Nurix Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NRIX?

Based on 17 analysts, the consensus for NRIX is Buy.

What is the market cap of NRIX?

Nurix Therapeutics's market capitalization is $2.61B, classifying it as a mid-cap company. Nurix Therapeutics operates in the Healthcare sector within the Biotechnology industry.